Furthermore, our results demonstrated that tumor progression in the chemotherapy-induced neutropenic mouse model was promoted by G-CSF, and the specific GGT inhibitor, GGsTop, prevented G-CSF-induced EL4 lymphoma progression. Here, GGT1 is linked to neoplasm.